Interferon-α and Autoimmune Thyroid Disease

Hepatitis C Virus Infection

Lauer, G. M., & Walker, B. D. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107053450107 · Cited by 3,033

An overview of the immune system

Parkin, J., & Cohen, B. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04904-7 · Cited by 1,593

Interferons α and β as Immune Regulators—A New Look

Biron, C. A. (2001) · Immunity · doi:10.1016/s1074-7613(01)00154-6 · Cited by 666

Autoimmune Thyroid Disease: Further Developments in Our Understanding*

Weetman, A. P., & McGregor, A. M. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-6-788 · Cited by 656

A survey of adverse events in 11 241 patients with chronic viral hepatitis treated with alfa interferon

Fattovich, G., Giustina, G., Favarato, S., & Ruol, A. (1996) · Journal of Hepatology · doi:10.1016/s0168-8278(96)80184-x · Cited by 483

Side effects of high-dose interferon therapy for chronic hepatitis C

Okanoue, T., Sakamoto, S., Itoh, Y., Minami, M., Yasui, K., Sakamoto, M., Nishioji, K., Katagishi, T., Nakagawa, Y., Tada, H., et al. (1996) · Journal of Hepatology · doi:10.1016/s0168-8278(96)80113-9 · Cited by 456

Molecular Pathways in Virus-Induced Cytokine Production

Mogensen, T. H., & Paludan, S. R. (2001) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.65.1.131-150.2001 · Cited by 418

Side effects of α interferon in chronic hepatitis C

Dusheiko, G. M. (1997) · Hepatology · doi:10.1002/hep.510260720 · Cited by 394

Autoimmune thyroid disease: further developments in our understanding

Weetman, A. P. (1994) · Endocrine Reviews · doi:10.1210/er.15.6.788 · Cited by 216

Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon‐α therapy

Marazuela, M., Garcı́a-Buey, L., González‐Fernández, B., García‐Monzón, C., Arranz, A., Borque, M. J., & Moreno‐Otero, R. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.751768.x · Cited by 210

Long-term outcomes and risk factors of thyroid dysfunction during pegylated interferon and ribavirin treatment in patients with chronic hepatitis C infection in Taiwan

Chang, Y.-K., Tseng, Y., Chen, K.-H., & Chen, K. (2019) · BMC Endocrine Disorders · doi:10.1186/s12902-019-0362-7 · Cited by 15

Interferon-alpha induced and ribavirin induced thyroid dysfunction in patients with chronic hepatitis C.

Nadeem, A., Hussain, M. M., Aslam, M. N., & Hussain, T. (2010) · Europe PMC (PubMed Central) · Cited by 14

Pegylated interferon-α2b and ribavirin combination therapy induces Hashitoxicosis followed by type 1 diabetes mellitus

Yagyu, H., Okada, K., Sato, S., Yamashita, Y., Okada, N., Osuga, J.-I., Nagasaka, S., Sugano, K., & Ishibashi, S. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.11.016 · Cited by 14

Side-effects of pegylated interferon plus ribavirin therapy with or without protease inhibitor direct acting antiviral agents during treatment of chronic hepatitis C virus infection

Hunyady, B., Kovács, B., & Battyáni, Z. (2011) · Orvosi Hetilap · doi:10.1556/oh.2011.29266 · Cited by 14

CXCL10 and CCL2 Chemokine Serum Levels in Patients With Hepatitis C Associated With Autoimmune Thyroiditis

Antonelli, A., Ferri, C., Fallahi, P., Ferrari, S. M., Frascerra, S., Pampana, A., Panicucci, E., Carpi, A., Nicolini, A., & Ferrannini, E. (2009) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2008.0090 · Cited by 14

Chronic hepatitis b with type I diabetes mellitus and autoimmune thyroiditis development during interferon alpha therapy

Köse, Ş., Gözaydın, A., Akkoçlu, G., & Ece, G. T. (2011) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.1632 · Cited by 13

Thyroid dysfunction incidence and risk factors in Chinese chronic hepatitis B patients treated with pegylated interferon alpha: A long‐term follow‐up study

Ma, Z., Qin, Y., Jia, Y., Xie, Y., Qi, X., Guo, Y., He, J., Zhang, Y., Li, F., Yu, J., et al. (2022) · Journal of Viral Hepatitis · doi:10.1111/jvh.13667 · Cited by 13

Hepatitis C as a systemic disease: virus and host immunologic responses underlie hepatic and extrahepatic manifestations

Okuse, C., Yotsuyanagi, H., & Koike, K. (2007) · Journal of Gastroenterology · doi:10.1007/s00535-007-2097-x · Cited by 13

Type B Insulin Resistance Developing During Interferon-α Therapy

Daniel, A. L., Houlihan, J. L., Blum, J. S., & Walsh, J. P. (2009) · Endocrine Practice · doi:10.4158/ep.15.2.153 · Cited by 13

Hypothyroidism and Myxedema Coma

Wiersinga, W. M. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00085-x · Cited by 13

Hepatitis C Infection, Treatment Regimens, and Thyroid Function Abnormalities

Tran, H. A. (2007) · The Endocrinologist · doi:10.1097/ten.0b013e3180dc91d3 · Cited by 13

Virus C genotype predisposes to primary hypothyroidism during interferon-α treatment for chronic hepatitis C

Pavan, M. H. P., Pavin, E. J., Gonçales, F. L., & Wittmann, D. E. Z. (2011) · The Brazilian Journal of Infectious Diseases · doi:10.1016/s1413-8670(11)70226-4 · Cited by 12

Peginterferon Alpha/Ribavirin Combination Therapy for the Treatment of Hepatitis C Infection

Zic, I. (2005) · Gastroenterology Nursing · doi:10.1097/00001610-200507000-00006 · Cited by 12

Thyrotoxic Hypokalemic Periodic Paralysis as the First Manifestation of Interferon-α–induced Graves Disease

Cesur, M., Gürsoy, A., Avcıoğlu, U., Erdoğan, M. F., Çorapçıoğlu, D., & Kamel, N. (2006) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000212660.59021.a3 · Cited by 12

B-Cell-Activating Factor Affects the Occurrence of Thyroid Autoimmunity in Chronic Hepatitis C Patients Treated with Interferon Alpha

Kajiyama, Y., Kikuchi, K., Takai, A., Hosoya, N., Hoshino, H., Hino, K., & Miyakawa, H. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/247973 · Cited by 11

Association of Interferon-Alpha and Ribavirin-Induced Thyroid Dysfunction with Severity of Disease and Response to Treatment in Pakistani Asian Patients of Chronic Hepatitis C

Nadeem, A., & Aslam, M. N. (2012) · Hepatitis Research and Treatment · doi:10.1155/2012/864315 · Cited by 11

Immunological Changes and Increased Expression of Myxovirus Resistance Protein A in Thyroid Tissue of Patients with Recent Onset and Untreated Graves' Disease

Hammerstad, S. S., Jahnsen, F. L., Tauriainen, S., Hyöty, H., Paulsen, T. H., Norheim, I., & Dahl‐Jørgensen, K. (2013) · Thyroid · doi:10.1089/thy.2013.0287 · Cited by 11

Safety of peginterferon in the treatment of chronic hepatitis C

Hashemi, N., Rossi, S., Navarro, V. J., & Herrine, S. K. (2008) · Expert Opinion on Drug Safety · doi:10.1517/14740330802423291 · Cited by 11

Treatment of Hepatitis C Infection

Stribling, R., Sussman, N., & Vierling, J. M. (2006) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2006.05.003 · Cited by 11

Depression and pegylated interferon-based hepatitis C treatment

Papafragkakis, H., Rao, M. S., Moehlen, M., Dhillon, S., & Martin, P. (2012) · International Journal of Interferon Cytokine and Mediator Research · doi:10.2147/ijicmr.s28901 · Cited by 10

Association between human leukocyte antigen (HLA) and interferon- induced thyroid diseases in four patients with HCV-related chronic hepatitis.

Labbadia, G., Martocchia, A., Mammarella, A., Paoletti, V., Rocco, A., Benvenuto, R., Antonella, P., D’URSO, R., Trabace, S., Musca, A., et al. (2005) · PubMed · Cited by 11

Analysis of clinical characteristics of thyroid disorders in patients with chronic hepatitis B treated with pegylated-interferon alpha

Liu, Y., Zheng, Y., Lin, X., Cao, Z., Lu, J., Ma, L., Ren, S., Zheng, S., Hu, Z., Xu, B., et al. (2023) · BMC Endocrine Disorders · doi:10.1186/s12902-023-01371-w · Cited by 10

Hepatitis C virus and autoimmunity

Böckle, B. C., & Sepp, N. T. (2010) · Autoimmunity Highlights · doi:10.1007/s13317-010-0005-5 · Cited by 10

The natural history of interferon-α induced thyroiditis in chronic hepatitis c patients: a long term study

Tran, H. A., Levett-Jones, T. L., Ianna, E. A., & Reeves, G. E. M. (2011) · Thyroid Research · doi:10.1186/1756-6614-4-2 · Cited by 10

Hepatitis C virus and human immunodeficiency virus coinfection: where do we stand?

Arends, J. E., Boucher, C. A., & Hoepelman, A. I. M. (2005) · PubMed · Cited by 10

A systematic review and meta-analysis of endocrine-related adverse events associated with interferon

Wang, L., Li, B., Zhao, H., Wu, P., Wu, Q., Chen, K., & Mu, Y.-M. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.949003 · Cited by 9

Interferon-Alpha-Induced Destructive Thyroiditis Followed by Graves' Disease in a Patient with Chronic Hepatitis C: A Case Report

Kim, B. K., Choi, Y. S., Park, Y., & Lee, S. U. (2011) · Journal of Korean Medical Science · doi:10.3346/jkms.2011.26.12.1638 · Cited by 9

The presence of thyroid peroxidase antibody of IgG2 subclass is a risk factor for thyroid dysfunction in chronic hepatitis C patients

Shao, C., Huo, N., Zhao, L., Gao, Y., Fan, X., Zheng, Y., Wang, L., Lu, H., Xu, X., & Guo, X. (2013) · European Journal of Endocrinology · doi:10.1530/eje-12-0775 · Cited by 9

Hashimoto’s Thyroiditis and Graves’ Disease in One Patient: The Extremes of Thyroid Dysfunction Associated with Interferon Treatment

Bishay, R. H., & Chen, R. C. Y. (2016) · Case Reports in Endocrinology · doi:10.1155/2016/6029415 · Cited by 9

The self‐antigen, thyroglobulin, induces antigen‐experienced CD4+ T cells from healthy donors to proliferate and promote production of the regulatory cytokine, interleukin‐10, by monocytes

Nielsen, C. H., Galdiers, M. P., Hedegaard, C. J., & Leslie, R. G. Q. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03183.x · Cited by 9

The swinging thyroid in hepatitis C infection and interferon therapy

Tran, H. A. (2009) · QJM · doi:10.1093/qjmed/hcp157 · Cited by 8

Thyroid Function Testing

Weiss, R. E., & Refetoff, S. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00078-0 · Cited by 8

Thyroid Function Outcomes after Pegylated Interferon-α and Ribavirin Therapy - For Chronic Hepatitis C

Tran, H. A., Reeves, G. E. M., Ianna, E. A., & Leembruggen, N. (2010) · Endocrine Practice · doi:10.4158/ep10036.or · Cited by 7

Cases of interferon-Alpha and Interferon-Beta-Induced Thyroiditis

Nonchev, B. (2010) · Folia Medica · doi:10.2478/v10153-010-0001-6 · Cited by 7

Extrahepatic Manifestations of Hepatitis C Virus: An Extending List

Soliman, A., Elhawari, S. A., Refaey, M., Ahmed, N. H., & Emara, M. (2012) · Afro-Egyptian Journal of Infectious and Endemic Diseases · doi:10.21608/aeji.2012.15811 · Cited by 7

Sonographie der Schilddrüse und Nebenschilddrüsen

Braun, B., & Blank, W. (2006) · Der Internist · doi:10.1007/s00108-006-1598-7 · Cited by 7

High prevalence of HCV (GT4)-related TSH abnormality among 13402 Egyptian patients treated with direct acting antiviral therapy

Eletreby, R., Said, M., Abdellatif, Z., Saad, Y., El‐Serafy, M., Dabes, H., Elsaeed, K., Elshazly, Y., & Doss, W. H. (2018) · Hepatology International · doi:10.1007/s12072-018-9845-2 · Cited by 6

Moyamoya in a Child Treated With Interferon for Recurrent Osteosarcoma

Buchbinder, D. K., Steinberg, G. K., Linetsky, M., & Casillas, J. (2010) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0b013e3181e5e1db · Cited by 6

Hashimoto’s Thyroiditis

Wiersinga, W. M. (2016) · Endocrinology · doi:10.1007/978-3-319-29195-6_7-1 · Cited by 6

Interferon alpha-induced non-immune thyrotoxicosis treated by plasmapheresis

Sayıner, Z. A., Eraydın, A., Metin, T., & Özkaya, M. (2017) · BMJ Case Reports · doi:10.1136/bcr-2017-221228 · Cited by 6

Autoimmune Thyroid Disease in Patients with Philadelphia-Negative ChronicMyeloproliferative Neoplasms Treated with Interferon-Alpha

Paulsrud, C., Hasselbalch, H. C., & Bjerrum, O. W. (2016) · doi:10.4172/jbrhd.1000102 · Cited by 5

Tirotoxicosis e hipertiroidismo

Carrera, C. B., Cabañas-Durán, M., Fernández, C., & García, J. A. R. (2020) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2020.07.002 · Cited by 6

The frequency of hypothyroidism and its relationship with HCV positivity in patients with thalassemia major in southern Iran.

Haghpanah, S., Jelodari, S., Karamifar, H., Saki, F., Rahimi, R., Sanctis, V. D., Dehbozorgian, J., & Karimi, M. (2018) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v89i1.5778 · Cited by 5

Course of Graves Disease in Interferon-Treated Patients With Chronic Hepatitis C Virus Infection and in Uninfected Patients

Minelli, R., Spagnoli, F., Marchesi, E., Venturi, N., Marina, M., Orlandini, A., Zardo, M., Ferrari, C. I., & Ceresini, G. (2013) · Journal of Investigative Medicine · doi:10.2310/jim.0000000000000000 · Cited by 5

Spontaneous Transient Graves' Thyrotoxicosis

Hidaka, Y., & Tatsumi, K. (2008) · Thyroid · doi:10.1089/thy.2008.0159 · Cited by 5

Rapid progression from subclinical to symptomatic overt hypothyroidism.

Heymann, R., & Brent, G. (2005) · Endocrine Practice · doi:10.4158/ep.11.2.115 · Cited by 5

Replicative Homeostasis III: implications for antiviral therapy and mechanisms of response and non-response

Sallie, R. (2007) · Virology Journal · doi:10.1186/1743-422x-4-29 · Cited by 5

Interferon‐induced thyroid dysfunction—not always transient

Wong, V. W., Cheng, A. Y., & Chan, H. L. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.05853.x · Cited by 5

Metabolic diseases and interferon immune responses

Zhou, H., Liu, C., Zhang, Y., & Zheng, H. (2025) · Interdisciplinary medicine · doi:10.1002/inmd.20240075 · Cited by 5

Drugs and Other Substances Interfering with Thyroid Function

Montanelli, L., Benvenga, S., Hegedűs, L. D., Vitti, P., Latrofa, F., & Duntas, L. H. (2018) · Endocrinology · doi:10.1007/978-3-319-29195-6_27-1 · Cited by 4

Interferon-induced thyroiditis during treatment of chronic hepatitis C.

Kozielewicz, D., & Halota, W. (2012) · PubMed · Cited by 4

37 Drugs that act on the immune system: cytokines and monoclonal antibodies

Vial, T., Descotes, J., Braun, F., & Behrend, M. (2007) · Side effects of drugs annual · doi:10.1016/s0378-6080(06)29037-8 · Cited by 3

The development of thyroid autoimmunity is potentially associated with the deficiency of vitamin D3 rather than vitamin D2 in euthyroid men

Luo, D., Zhang, C., Gao, B., Wang, D., Chen, Z., Chen, K., Li, B.-J., Leng, S., & Li, J. (2025) · Thyroid Research · doi:10.1186/s13044-025-00226-x · Cited by 3

Tiroiditis autoinmune inducida por interferón en pacientes con infección por virus de la hepatitis C.

Valdivia, J. L. P., & Pinto, M. E. (2011) · Revista Peruana de Medicina Experimental y Salud Pública · doi:10.1590/s1726-46342011000200028 · Cited by 3

Tiroiditis subaguda inducida por el tratamiento con interferón alfa pegilado y ribavirina en un caso de hepatitis crónica por virus C

Galiana, P. A., Pérez-Lázaro, A., Sancho-Tello, V. A., Merino-Torres, J. F., Berenguer, M., & Piñón-Sellés, F. (2009) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(09)70844-7 · Cited by 3

The swinging thyroid in hepatitis C infection and interferon therapy

Tran, H. A. (2009) · BMJ Case Reports · doi:10.1136/bcr.07.2008.0464 · Cited by 3

Thyroid Disorders in Hepatitis C Patients Treated or Not With α-Interferon and Ribavirin

Santos, S. R. X., Ferreira, M. S., Borges, A. S., Pinto, R. D. M. C., Fernandes, M. L. P. M., & Jorge, P. T. (2010) · The Endocrinologist · doi:10.1097/ten.0b013e3181dfcb01 · Cited by 3

Hyperthyroïdie

Wémeau, J.-L., Cardot-Bauters, C., d'Herbomez-Boidein, M., Perimenis, P., & Cephise-Velayoudom, F. L. (2006) · EMC - Endocrinologie - Nutrition · doi:10.1016/s1155-1941(06)41940-5 · Cited by 4

Hypothyroidism, Causes of

Wiersinga, W. M. (2004) · Elsevier eBooks · doi:10.1016/b0-12-475570-4/00724-1 · Cited by 3

The Uncertain Natural History of Thyrotoxic Patients Treated With Combination Interferon Alfa-2β and Ribavirin

Tran, H. A. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.9.1072-a · Cited by 3

Human monoclonal antibodies to IFN-α for the treatment of autoimmune diseases

(2006) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.16.2.221 · Cited by 3

Autoimmune and non-autoimmune thyroid dysfunction in HCV infected and HCV–HIV co-infected patients before and after interferon alpha therapy: A prospective study

Löwenstein, A., Fainboim, H. A., Reyes, A., Lutzky, C., Ameigeiras, B., Schroder, T., & Russmann, M. L. E. (2019) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2019.04.012 · Cited by 2

Immunopathogenesis of Graves’ Disease

MORSHED, S. A., Latif, R., & Davies, T. F. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-478-4_28 · Cited by 2

Managing the Side Effects of Therapy

Cooper, C. (2011) · Springer eBooks · doi:10.1007/978-1-4614-1192-5_14 · Cited by 2

Thyroiditis and Other More Unusual Forms of Hyperthyroidism

Meek, S., & Smallridge, R. C. (2009) · CRC Press eBooks · doi:10.3109/9781420070651-4 · Cited by 2

Thyroid Function Testing

Weiss, R. E., & Refetoff, S. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00077-0 · Cited by 2

Management of thyrotoxicosis without hyperthyroidism

Wiersinga, W. M. (2011) · doi:10.1093/med/9780199235292.003.3228 · Cited by 2

Acquired factor VIII inhibitor in a patient with multiple sclerosis treated with interferon β-1a

Pandya, D. P., Hellerslia, V. T., & Gettings, E. J. (2020) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2020.577146 · Cited by 2

Exploring causal links between autoimmune liver diseases, chronic hepatitis C, and thyroid disorders: Evidence from NHANES and GWAS studies

Nie, Q., Jiang, Y., Liang, Q., Li, M., Huang, C., Yongwei, Y., Qiu, T., Ma, X., & Li, J. (2025) · Medicine · doi:10.1097/md.0000000000044112 · Cited by 1

Type I and III interferons in asthma and respiratory infections: New insights for potential treatments

Jafari, Z., Nazhdi, Z. A., EmamAlizadeh, M., & Athari, S. S. (2026) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2026.106960 · Cited by 1

Intravenous Immunoglobulins (IVIG) Enhance In vitro Activation of Neutrophils in C57BL/6 but not in CBA Mice

Basyreva, L. Y. (2014) · Immunome Research · doi:10.4172/1745-7580.1000068 · Cited by 1

The Multifaceted Features of HCV Infection Beyond the Liver

Koike, K. (2016) · Springer eBooks · doi:10.1007/978-4-431-56101-9_2 · Cited by 1

Patologia sistemica da virus dell'epatite C: la crioglobulinemia mista e altre manifestazioni extraepatiche

Visconti, M. F., Campanini, M., Fontanella, A., Nardi, R., & Uomo, G. (2016) · Italian Journal of Medicine · doi:10.4081/itjm.q.2016.1 · Cited by 1

Thyroid Nodules and Multinodular Goiter

Gharib, H. (2009) · CRC Press eBooks · doi:10.3109/9781420070651-6 · Cited by 1

Extrahepatic Manifestations of Hepatitis C Virus Infection

Karaca, Ç. (2019) · Springer eBooks · doi:10.1007/978-3-030-03757-4_10 · Cited by 1

Autoimmune Hashimoto’s Thyroiditis and Hypothyroidism: Novel Aspects

Kostoglou‐Athanassiou, I., Athanassiou, L., & Athanassiou, P. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.102785 · Cited by 1

DOENÇA AUTO-IMUNE DE TIREÓIDE E DISFUNÇÃO TIREOIDIANA EM PACIENTES COM ARTRITE REUMATÓIDE

Gonçalves, F. T. (2007) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1

Thyrotoxicosis During Pegylated Interferon Therapy in a Patient With Chronic Hepatitis C Virus

Tran, H. A., & Wang, X. (2006) · Endocrine Practice · doi:10.4158/ep.12.2.231 · Cited by 1

Graves' Disease

Prummel, M. F. (2004) · Elsevier eBooks · doi:10.1016/b0-12-475570-4/00562-x · Cited by 1

Yersinia Enterocolitica Infections and Autoimmune Thyroid Diseases

Prummel, M. F., & Wiersinga, W. M. (2004) · Elsevier eBooks · doi:10.1016/b978-044451271-0.50029-6 · Cited by 1

Thyroid-associated Ophthalmopathy in a Chronic Hepatitis C Patient during IFN-|α Therapy

MostafaAlavi, M., & Alavian, S. M. (2005) · Hepatitis Monthly

Interferon-Induced Hyperthyroidism

Aoun, P., & Cooper, D. S. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-103-5_5

Molecular Etiology of Graves’ Disease and Associated Ophthalmopathy

Planck, T. (2010) · Lund University Publications (Lund University)

Endocrine Manifestations of HCV-Positive Cryoglobulinemia

Antonelli, A., Ferri, C., Ferrari, S. M., Colaci, M., Corrado, A., Domenicantonio, A. D., & Fallahi, P. (2011) · Springer eBooks · doi:10.1007/978-88-470-1705-4_24

Disfunción tiroidea autoinmunitaria de presentación variable en una paciente tratada con interferón-α

Pinés-Corrales, P. J., Watt, M. P., de la Calle, H., Alonso-Blanco, M., & Castellanos, R. B. (2006) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(06)71072-5

Dysthyroïdie lors d’une hépatite C

Ouahabi, H. E., & Ajdi, F. (2012) · La Presse Médicale · doi:10.1016/j.lpm.2011.12.002

Hepatitis C in chronic kidney disease and kidney transplantation : With special reference to epidemiology and treatment

Bruchfeld, A. N. (2003) · Figshare

Busca de fatores genéticos associados à resposta ao tratamento do HCV genótipo 3.

Luna, A. L. (2012) · doi:10.11606/t.42.2012.tde-09112012-105715

Determination of Whether Vitiligo is a Contraindication to Interferon Therapy in Chronic Hepatitis C

Alavian, S. M. (2014) · Journal of Skin and Stem Cell · doi:10.17795/jssc16639

Role of Dendritic Cells in Autoimmunity in Aged Humans

Gupta, S. (2014) · Immunome Research · doi:10.4172/1745-7580.1000067

Autoimmune Thyroiditis during Antiviral Therapy with Peginterferon

Roh, J. M., Yoo, J. S., Lee, Y. B., An, H. R., Choi, H. K., Jung, K. T., Park, J. S., Lee, K. S., & Kim, K. R. (2010) · Journal of Korean Endocrine Society · doi:10.3803/jkes.2010.25.1.68

Unraveling the Genetics of Lymphocytic Thyroiditis

Sundberg, K. (2012)

Comparative Study of Widely Used Chemotherapeutic Agent Paclitaxel Using HeLa and Vero Cell Lines

Qazi, M. H. (2014)

THE ROLE OF HSPs IN MHC CLASS II PRESENTATION OF SELECT ANTIGENS

Houlihan, J. L. (2010) · IUScholarWorks (Indiana University) · doi:10.7912/c2/1695

Manifestations extrahépatiques au cours de l'infection par le virus de l'hépatite C

Sène, D., & Cacoub, P. (2010) · EMC - Hépatologie · doi:10.1016/s1155-1976(09)50376-2

Endocrine and Metabolic Emergencies in HIV/AIDS

Samaras, K. (2018) · doi:10.1002/9781119374800.ch8

VIRAL HEPATITIS C PATIENTS; HYPOTHYROIDISM WITH RELATION OF INTERFERON TREATED PATIENTS

Rajput, A., Das, B., Kumar, S., Ansari, R., Kumar, B., & Qadeer, A. (2016) · The Professional Medical Journal · doi:10.17957/tpmj/16.3481

Subacute Thyroiditis Associated with Interferon Therapy of Polycythemia Vera: Report of a Case and Literatures Review

李, 晟. (2017) · Medical Diagnosis · doi:10.12677/md.2017.71002

VIRAL HEPATITIS C PATIENTS

Rajput, A., Das, B., Kumar, S., Ansari, R., Kumar, B., & Qadeer, A. (2016) · The Professional Medical Journal · doi:10.29309/tpmj/2016.23.10.1739

Environmental triggers of thyroiditis: Hepatitis C and interferon-α

Menconi, F., Hasham, A., & Tomer, Y. (2011) · Journal of Endocrinological Investigation · doi:10.1007/bf03346699 · Cited by 57

Incidence of autoimmune thyroiditis in interferon-alpha treated and untreated patients with chronic hepatitis C virus infection.

Rocco, A., Gargano, S., Provenzano, A., Nardone, M., Sanctis, V. D., Altavilla, N., Lv, C., & Grimaldi, F. M. (2001) · PubMed · Cited by 20

The influence of interferon alpha on the induction of autoimmune thyroiditis in patients treated for chronic viral hepatitis type C.

Krupińska, J., Wawrzynowicz‐Syczewska, M., Urbanowicz, W., Pobłocki, J., & Syrenicz, A. (2011) · PubMed · Cited by 9

Interferon Alpha Treatment and Thyroid Dysfunction

Tomer, Y., Blackard, J. T., & Akeno, N. (2007) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2007.07.001 · Cited by 142

Interferon induced thyroiditis

Tomer, Y., & Menconi, F. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.07.004 · Cited by 112